Ret/PTC3 is the most frequent form of gene rearrangement in papillary thyroid carcinomas in Japan

Journal of Human Genetics

Volumn 44, Issue 2, 1999, Pages 96-102

  Kitamura, Yutaka ^a   Minobe, Kaori ^a   Nakata, Tomoko ^a   Shimizu, Kazuo ^a   Tanaka, Shigeo ^a   Fujimori, Minoru ^b   Yokoyama, Shiro ^b   Ito, Koichi ^c   Onda, Masahiko ^a   Emi, Mitsuru ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c ITO HOSPITAL   (Japan)

Author keywords

Papillary thyroid carcinoma; Rearrangement; RET proto oncogene; TRK proto oncogene

Indexed keywords

COMPLEMENTARY DNA;

ADULT; ARTICLE; CLINICAL ARTICLE; GENE FUSION; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; JAPAN; PROTO ONCOGENE; THYROID PAPILLARY CARCINOMA;

ADULT; AMINO ACID SEQUENCE; BASE SEQUENCE; CARCINOMA, PAPILLARY; DNA, COMPLEMENTARY; GENE REARRANGEMENT; HUMANS; JAPAN; MOLECULAR SEQUENCE DATA; NUCLEIC ACID HYBRIDIZATION; ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYROID NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 0033049340     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100380050117     Document Type: Article

References (43)

1. Bongarzone I, Pierotti M, Monzini N, Mondellini P, Manenti G, Donghi R, Pilotti S, Grieco M, Santoro M, Fusco A, Vecchio G, Della Porta G (1989) High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma. Oncogene 4: 1457-1462
2. Bongarzone I, Monizini N, Borrello M, Carcano C, Ferraresi G, Arighi E, Mondellini P, Della Porta G, Pierotti M (1993) Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RIα of cyclic AMP-dependent protein kinase A. Mol Cell Biol 13: 358-366
3. Bongarzone I, Butti M, Coronelli S, Borrello M, Santoro M, Mondellini P, Pilotti S, Fusco A, Della Porta G, Pierotti M (1994) Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas. Cancer Res 54: 2979-2985
4. Bounacer A, Wicker R, Caillou B, Cailleux A, Sarasin A, Schlumberger M, Suarez H (1997) High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation. Oncogene 15: 1263-1273
5. Chen Z (1996) Simple modifications to increase specificity of the 5′ RACE procedure. Trends Genet 12: 87-88
6. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159
7. Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Laimore TC, Howe JR, Moley JF, Goodfellow PJ, Wells SA Jr (1993) Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet 2: 851-856
8. Fabien N, Paulin C, Santoro M, Berger N, Grieco M, Galvain D, Barbier Y, Doubois P, Fusco A (1992) Detection of RET oncogene activation in human papillary thyroid carcinomas by in situ hybridization. Br J Cancer 66: 1094-1098
9. Fugazzola L, Pierotti M, Vigano E, Pacini F, Vorontsova T, Bongarzone I (1996) Molecular and biochemical analysis of RET/ PTC4, a novel oncogenic rearrangement between RET and ELE1 genes, in a posl-Chernobyl papillary thyroid cancer. Oncogene 13: 1093-1097
10. Greco A, Pierotti M, Bongarzone I, Pagliardini S, Lanzi C, Della Porta G (1992) TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas. Oncogene 7: 237-242
11. Greco A, Mariani C, Miranda C, Lupas A, Pagliardini S, Ponati M, Pierotti M (1995) The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain. Mol Cell Biol 15: 6118-6127
12. Grieco M, Santoro M, Berlingieri M, Melillo R, Donghi R, Bongarzone I, Pierotti M, Della Porta G, Fusco A, Vecchio G (1990) PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell 60: 557-563
13. Hofstra RMW, Landsvater RM, Ceccherini I, Stulp RP, Stelwagen T, Luo Y, Pasini B, Höppener JWM, van Amstel HKP, Romeo G, Lips CJM, Buys CHCM (1994) A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 367: 375-376
14. Ishizaka Y, Kobayashi S, Ushijima T, Hirohashi S, Sugimura T, Nagao M (1991) Detection of retTPC/PTC transcripts in thyroid adenomas and adenomatous goiter by an RT-PCR method. Oncogene 6: 1667-1672
15. TPC oncogene in human thyroid cancers. Oncogene 7: 1331-1337
16. Jhiang S, Smanik P, Mazzaferri E (1994) Development of a single-step duplex RT-PCR detecting different forms of ret activation, and identification of the third form of in vivo ret activation in human papillary thyroid carcinoma. Cancer Lett 78: 69-76
17. Jhiang S, Sagartz J, Tong Q, Parker T, Capen C, Cho J, Xing S, Ledent C (1996) Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas. Endocrinology 137: 375-378
18. Jing S, Wen D, Yu Y, Holst P, Lou Y, Fang M, Tamir R, Antonio L, Hu Z, Cupples R, Louis J, Hu S, Altrock B, Fox G (1996) GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell 85: 1113-1124
19. Kitamura Y, Scavarda N, Wells SA Jr, Jackson C, Goodfellow PJ (1995) Two maternally derived missense mutations in the tyrosine kinase domain of the RET protooncogene in a patient with de novo MEN 2B. Hum Mol Genet 4: 1987-1988
20. Kitamura Y, Goodfellow PJ, Shimizu K, Nagahama M, Ito K, Kitagawa W, Akasu H, Takami H, Tanaka S, Wells SA Jr (1997) Novel germline RET proto-oncogene mutations associated with medullary thyroid carcinoma (MTC): Mutation analysis in Japanese patients with MTC. Oncogene 14: 3103-3106
21. Klein R, Jing S, Nanduri V, O'Rourke E, Barbacid M (1991) The trk proto-oncogene encodes a recptor for nerve growth factor. Cell 65: 189-197
22. Klein R, Sherman D, Ho WH, Stone D, Bennett GL, Moffat B, Vandlen R, Simmons L, Gu Q, Hongo JA, Devaux B, Poulsen K, Armanini M, Nozaki C, Asai N, Goddard A, Phillips H, Henderson CE, Takahashi M, Rosenthal A (1997) A GPI-linked protein that interacts with Ret to form a candidate neurturin receptor. Nature 387: 717-721
23. Klugbauer S, Lengfelder E, Demidchik E, Rabes H (1996) A new form of RET rearrangement in thyroid carcinomas of children after the Chernobyl reactor accident. Oncogene 13: 1099-1102
24. Martin-Zanca D, Hughes S, Barbacid M (1986) A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences. Nature 319: 743-748
25. Minoletti F, Butti M, Coronelli S, Miozzo M, Sozzi G, Pilotti S, Tunnacliffe A, Pierotti M, Bongarzone I (1994) The two genes generating RET/PTC3 are localized in chromosomal band 10q11.2. Genes Chromosom Cancer 11: 51-57
26. Motomura T, Nikiforov YE, Namba H, Ashizawa K, Nagataki S, Yamashita S, Fagin JA (1998) ret Rearrangements in Japanese pediatric and adult papillary thyroid cancers. Thyroid 8: 485-489
27. Mulligan LM, Know JBJ, Healey CS, Elsdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, Papi L, Ponder MA, Telenius H, Tunnacliff L, Ponder BAJ (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363: 458-460
28. Nakamura Y (1993) Multi-step carcinogenesis of colorectal cancer. Jpn J Hum Genet 38: 23-24
29. Nakamura Y (1996) Application of DNA markers to clinical genetics. Jpn J Hum Genet 41: 1-14
30. Namba H, Yamashita S, Pei H, Ishikawa N, Villadolid M, Tominaga T, Kimura H, Tsuruta M, Yokoyama N, Izumi M, Ishigaki J, Ito K, Nagataki S (1991) Lack of PTC gene (ret proto-oncogene rearrangement) in human thyroid tumors. Endocrinol Japon 38: 627-632
31. Pierotti M, Santoro M, Jenkins R, Sozzi G, Bongarzone I, Grieco M, Monzini N, Miozzo M, Herrmann M, Fusco A, Hay I, Della Porta G, Vecchio G (1992) Characterization of an inversion on the long arm of chromosome 10 juxtaposing D 10S170 and ret and creating the oncogenic sequence ret/ptc. Proc Natl Acad Sci USA 89: 1616-1620
32. Rabbits T (1994) Chromosomal translocations in human cancer. Nature 372: 143-149
33. Santoro M, Cariomagno F, Hay I, Herrmann M, Grieco M, Melillo R, Pierotti M, Bongarzone I, Della Porta G, Berger N, Peix J, Paulin C, Fabien N, Vecchio G, Jenkins R, Fusco A (1992) Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype. J Clin Invest 89: 1517-1522
34. Santoro M, Dathan N, Berlingieri M, Bongarzone I, Paulin C, Grieco M, Pierotti M, Vecchio G, Fusco A (1994) Molecular characterization of RET/PTC3; a novel rearranged version of the RET proto-oncogene in a human thyroid papillary carcinoma. Oncogene 9: 509-516
35. Santoro M, Chiappetta G, Cerrato A, Salvatore D, Zhang L, Manzo G, Picone A, Portella G, Giovanni S, Vecchio G, Fusco A (1996) Development of thyroid papillary carcinomas secondary to tissue-specific expression of the ret/PTC1 oncogene in transgenic mice. Oncogene 12: 1821-1826
36. Smanik P, Furminger T, Mazzaferri E, Jhiang S (1995) Breakpoint characterization of the ret/PTC oncogene in human papillary thyroid carcinoma. Hum Mol Genet 4: 2313-2318
37. Tsukamoto K, Haruta K, Shiba T, Emi M (1998) Isolation and mapping of a polymorphic CA repeat sequence at the human interleukin 6 locus. J Hum Genet 43: 71-72
38. Tung WS, Shevlin DW, Kaleem Z, Tribune DJ, Wells SA Jr, Goodfellow PJ (1997) Allelotype of follicular thyroid carcinomas reveals genetic instability consistent with frequent nonjunctional chromosomal loss. Genes Chromosom Cancer 19: 43-51
39. Ullrich A, Schlessinger J (1990) Signal transduction by receptors with tyrosine kinase activity. Cell 61: 203-212
40. Viglietto G, Chiappetta G, Marinez Tello F, Fukunaga F, Tallini G, Rigopoulou D, Visconti R, Mastro A, Santoro M, Fusco A (1995) RET/PTC oncogene activation is an early event in thyroid carcinogenesis. Oncogene 11: 1207-1210
41. Wajjwalku W, SN, Hasegawa Y, Miyazaki K, Satoh Y, Funahashi H, Matsuyama M, Takahashi M (1992) Low frequency of rearrangements of the ret and trk proto-oncogenes in Japanese thyroid papillary carcinomas. Jpn J Cancer Res 83: 671-675
42. Ward L, Brenta G, Medvedovic M, Fagin J (1998) Studies of allelic loss in thyroid tumors reveal major differences in chromosomal instability between papillary and follicular carcinomas. J Clin Endocrinol Metab 83: 525-530
43. Williams G, Rooney S, Thomas G, Cummins G, Williams E (1996) RET activation in adult and childhood papillary thyroid carcinoma using a reverse transcriptase-n-polymerase chain reaction approach on archival-nested material. Br J Cancer 74: 585-589